STK39 interacts with MAPK14 to facilitate cardiomyocyte pyroptosis in septic cardiomyopathy by inducing NLRP3 inflammasome.
STK39 is identified as a novel upstream regulator of NLRP3 inflammasome-mediated pyroptosis in SCM through the MAPK14/ELK1 signaling axis and suggests that STK39 may serve as a potential molecular target for SCM.